Bloomberg Law

Publish Date
Patent Judges Review Fewer Challenges as Agency Priorities Shift
Bloomberg Law
Patent Eligibility Restoration Act Would Fuel US Competitiveness

In a recent op-ed for Bloomberg Law, C4IP Board Members and retired Federal Circuit Judges Paul Michel and Kathleen O’Malley argue that...

Bloomberg Law
Bill to Lower Bar for Patent Injunction Re-Sparks ‘Troll’ Fight
Bloomberg Law
Voice Actors’ AI Suit Confronts Federal Publicity-Rights Gap
Bloomberg Law
Quintet of Ex-Patent Office Officials Slam Proposed Rulemaking
Bloomberg Law
AI Copyright Bill Thrills Artists. Developers Call It Unworkable
Bloomberg Law
Lawmakers Lack Serious Engagement in IP Issues, Scorecard Says
Bloomberg Law
Backlash Builds Over Biden Plan for Seizing Drug Patents
Bloomberg Law
White House’s Drug Patent Plan Undercuts Research and Innovation

Merrill Matthews, a resident scholar with the Institute for Policy Innovation, recently published an opinion piece in RealClearHealth calling attention to the...

Bloomberg Law
Biden Drug Patent Seizures Would Test Scope of Government Power
Bloomberg Law
Ex-Patent, Commerce Officials Ask Biden to Skip Covid IP Waiver

Former Department of Commerce and US Patent and Trademark Office officials urged President Joe Biden to oppose a World Trade Organization proposal...

Bloomberg Law
Biden AI Order Sets Patent Office Deadline On Invention Controls
Bloomberg Law
Op-Eds:

Op-Eds:

Patent Office Rulemaking Can Curb Abuses via America Invents Act,

07/19/2023

Op-Eds:

Op-Eds:

House Patent Troll Bill Would Shield Pirates, Not Small Inventors,

06/14/2023

Op-Eds:

Op-Eds:

Don’t Know if Your Child Has Strep? Thank the U.S. Supreme Court,

05/31/2023

Op-Eds:

Op-Eds:

Humira Shows That America’s Patent Innovation System Is Working,

02/24/2023

Op-Eds:

Op-Eds:

Scapegoating Patents Won’t Lower Drug Prices,

10/17/2022

News:

News:

Patents for Human Genes, Diagnostic Tests Generate Policy Debate,

10/17/2022

Scroll to Top